These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 37122754)

  • 1. Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer.
    Rao DY; Huang DF; Si MY; Lu H; Tang ZX; Zhang ZX
    Front Immunol; 2023; 14():1142539. PubMed ID: 37122754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome-derived miR-210 involved in resistance to osimertinib and epithelial-mesenchymal transition in EGFR mutant non-small cell lung cancer cells.
    Hisakane K; Seike M; Sugano T; Yoshikawa A; Matsuda K; Takano N; Takahashi S; Noro R; Gemma A
    Thorac Cancer; 2021 Jun; 12(11):1690-1698. PubMed ID: 33939301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal epidermal growth factor receptor is involved in HPV-16 E7-induced epithelial-mesenchymal transition of non-small cell lung cancer cells: A driver of signaling in vivo.
    Zhou Z; Wu X; Zhan R; Li X; Cheng D; Chen L; Wang T; Yu H; Zhang G; Tang X
    Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 36224722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes: a new perspective in EGFR-mutated lung cancer.
    Jouida A; McCarthy C; Fabre A; Keane MP
    Cancer Metastasis Rev; 2021 Jun; 40(2):589-601. PubMed ID: 33855679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research Progress of the Role of EMT in EGFR-TKIs Resistance 
of Non-small Cell Lung Cancer].
    Yu L; Huang S; Lv W; He Z; Hu J
    Zhongguo Fei Ai Za Zhi; 2018 Dec; 21(12):907-911. PubMed ID: 30591098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial-mesenchymal transition.
    Liu K; Chen X; Wu L; Chen S; Fang N; Cai L; Jia J
    BMC Pulm Med; 2021 May; 21(1):163. PubMed ID: 33992097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer.
    Bronte G; Bravaccini S; Bronte E; Burgio MA; Rolfo C; Delmonte A; Crinò L
    Biol Rev Camb Philos Soc; 2018 Nov; 93(4):1735-1746. PubMed ID: 29671943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes from
    Jouida A; O'Callaghan M; Mc Carthy C; Fabre A; Nadarajan P; Keane MP
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance.
    Lobb RJ; van Amerongen R; Wiegmans A; Ham S; Larsen JE; Möller A
    Int J Cancer; 2017 Aug; 141(3):614-620. PubMed ID: 28445609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy.
    Zhao Y; Wang H; He C
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3653-3664. PubMed ID: 34661758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells.
    Vad-Nielsen J; Gammelgaard KR; Daugaard TF; Nielsen AL
    Lung Cancer; 2019 Jun; 132():132-140. PubMed ID: 31097086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule.
    Lawal B; Wu ATH; Huang HS
    Front Immunol; 2022; 13():872470. PubMed ID: 35655775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells.
    Takenaka T; Nakai S; Katayama M; Hirano M; Ueno N; Noguchi K; Takatani-Nakase T; Fujii I; Kobayashi SS; Nakase I
    Int J Pharm; 2019 Dec; 572():118762. PubMed ID: 31610280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification.
    La Monica S; Caffarra C; Saccani F; Galvani E; Galetti M; Fumarola C; Bonelli M; Cavazzoni A; Cretella D; Sirangelo R; Gatti R; Tiseo M; Ardizzoni A; Giovannetti E; Petronini PG; Alfieri RR
    PLoS One; 2013; 8(10):e78656. PubMed ID: 24167634
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Hu C; Zhou A; Hu X; Xiang Y; Huang M; Huang J; Yang D; Tang Y
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K/AKT signalling pathway.
    Liu X; Jiang T; Li X; Zhao C; Li J; Zhou F; Zhang L; Zhao S; Jia Y; Shi J; Gao G; Li W; Zhao J; Chen X; Su C; Ren S; Zhou C
    J Cell Mol Med; 2020 Jan; 24(2):1529-1540. PubMed ID: 31894895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.
    Thomson S; Petti F; Sujka-Kwok I; Epstein D; Haley JD
    Clin Exp Metastasis; 2008; 25(8):843-54. PubMed ID: 18696232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal long non-coding RNA SOX2 overlapping transcript enhances the resistance to EGFR-TKIs in non-small cell lung cancer cell line H1975.
    Zhou D; Xia Z; Xie M; Gao Y; Yu Q; He B
    Hum Cell; 2021 Sep; 34(5):1478-1489. PubMed ID: 34244990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases.
    Jiang J; Lu Y; Chu J; Zhang X; Xu C; Liu S; Wan Z; Wang J; Zhang L; Liu K; Liu Z; Yang A; Ren X; Zhang R
    J Nanobiotechnology; 2024 Apr; 22(1):159. PubMed ID: 38589859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective exosome-focused translational research for afatinib study of non-small cell lung cancer patients expressing EGFR (EXTRA study).
    Okuma Y; Morikawa K; Tanaka H; Yokoyama T; Itani H; Horiuchi K; Nakagawa H; Takahashi N; Bessho A; Soejima K; Kishi K; Togashi A; Kanai Y; Ueda K; Horimoto K; Matsutani N; Seki N
    Thorac Cancer; 2019 Feb; 10(2):395-400. PubMed ID: 30536780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.